Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study - Concepedia

Concepedia

Publication | Open Access

Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study

DOI Full Paper Access

72

Citations

16

References

2021

Year

Szu‐Min Hsieh, Wang-Da Liu, Yu‐Shan Huang, Yi‐Jiun Lin, Erh-Fang Hsieh, Wei‐Cheng Lian, Charles Chen, Robert S. Janssen, Shin‐Ru Shih, Chung‐Guei Huang,

EClinicalMedicine

References

	Year	Citations

Page 1